إعلان
إعلان
MREO
Mereo BioPharma Group plc - ADR
0.49
USDبرعاية
+0.11
+29.03%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
0.54
+0.05
+9.63%
تقارير أرباح MREO
النسبة الإيجابية المفاجئة
MREO تفوق 1 من 6 آخر التقديرات.
17%
التقرير التالي
بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$17.85M
/$0.00
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-100.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-100.00%
Mereo BioPharma Group plc - ADR earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, MREO reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.02 USD, resulting in a 59.68% surprise. Revenue reached --, compared to an expected 11.90 مليون, with a -100.00% difference. The market reacted with a +5.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of 0.00 USD, with revenue projected to reach 17.85 مليون USD, implying an نقصان of -100.00% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Mereo BioPharma Group plc - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Mereo BioPharma Group plc - ADR reported EPS of -$0.01, beating estimates by 59.68%, and revenue of $0.00, -100% below expectations.
How did the market react to Mereo BioPharma Group plc - ADR's Q3 2025 earnings?
The stock price moved up 5.65%, changed from $1.77 before the earnings release to $1.87 the day after.
When is Mereo BioPharma Group plc - ADR expected to report next?
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
What are the forecasts for Mereo BioPharma Group plc - ADR's next earnings report?
Based on 10
المحللين, Mereo BioPharma Group plc - ADR is expected to report EPS of -- and revenue of $17.85M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان